Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenoma × Mesalamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms, Hereditary Nonpolyposis 2 Colorectal Neoplasms 2 Recurrence 1 Psoriasis 1 Neoplasms 1 Lymphoma, Follicular 1 Inflammatory Bowel Diseases 1 Colonic Neoplasms 1 Colitis, Ulcerative 1 Adenoma 1

Interventions

Colonoscopy 14 Water 3 Aspirin 3 Ursodeoxycholic Acid 2 Sunitinib 2 Occult Blood 2 Narrow Band Imaging 2 Folic Acid 2 Endoscopic Mucosal Resection 2 pegvisomant 1 gadolinium ethoxybenzyl DTPA 1 defactinib 1 Polyethylene Glycols 1 Methods 1 Mesalamine 1 Mass Screening 1 Injections 1 Indocyanine Green 1 Gastroscopy 1 Endoscopy 1 Early Detection of Cancer 1 Diet, Fat-Restricted 1 Diagnostic Tests, Routine 1 Cholecystectomy 1 Celecoxib 1 Calcium Carbonate 1 Calcitriol 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01894685 2015-12-08

Mesalazine Effects in Sporadic Colorectal Adenoma Patients

UMC Utrecht

Phase 2 Completed

Adenoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡